Singapore markets closed

Augmedix, Inc. (AUGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.8200-0.2000 (-9.90%)
At close: 04:00PM EDT
1.9900 +0.17 (+9.34%)
After hours: 04:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 88.26M
Enterprise value 69.01M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)3.06
Price/book (mrq)4.86
Enterprise value/revenue 2.83
Enterprise value/EBITDA -4.41

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-69.67%
S&P500 52-week change 3-5.29%
52-week high 36.2200
52-week low 31.8200
50-day moving average 32.6376
200-day moving average 33.5352

Share statistics

Avg vol (3-month) 329.55k
Avg vol (10-day) 338.53k
Shares outstanding 537.4M
Implied shares outstanding 6N/A
Float 812.39M
% held by insiders 117.21%
% held by institutions 158.40%
Shares short (12 May 2022) 434.61k
Short ratio (12 May 2022) 41.08
Short % of float (12 May 2022) 40.24%
Short % of shares outstanding (12 May 2022) 40.09%
Shares short (prior month 13 Apr 2022) 471.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -77.52%
Operating margin (ttm)-77.91%

Management effectiveness

Return on assets (ttm)-33.09%
Return on equity (ttm)-219.79%

Income statement

Revenue (ttm)24.36M
Revenue per share (ttm)0.77
Quarterly revenue growth (yoy)45.80%
Gross profit (ttm)10.01M
EBITDA -18.32M
Net income avi to common (ttm)-18.88M
Diluted EPS (ttm)-0.5990
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)36.65M
Total cash per share (mrq)0.98
Total debt (mrq)17.4M
Total debt/equity (mrq)95.75
Current ratio (mrq)3.04
Book value per share (mrq)0.49

Cash flow statement

Operating cash flow (ttm)-17.45M
Levered free cash flow (ttm)-12.58M